Association of Insurance Types and Survival in Acute Promyelocytic Leukemia (APL)

Authors

Prajwal Dhakal
Elizabeth R. Lyden
Utsav Joshi, Rochester Regional HealthFollow
Avantika Pyakuryal
Krishna Gundabolu
Vijaya Raj Bhatt, University of Nebraska Medical Center

Department

Internal Medicine

Document Type

Conference Proceeding

Publication Title

Blood

Conference Name

ASH Annual Meeting

Conference Date

2021-11-05

Abstract

Introduction: Health insurance, or lack thereof, is a significant barrier to health care access in the United States. Patients without insurance or with inadequate coverage are more likely to delay or forego treatment, even with acute illness or significant symptoms, leading to worse health outcomes. We aimed to analyze if insurance types impacted one-month mortality and overall survival (OS) in younger patients with APL.

First Page

4129

DOI

10.1182/blood-2021-151055

Volume

138

Issue

Supplement 1

Publication Date

11-23-2021

Comments

906.Outcomes Research-Myeloid Malignancies

Recommended Citation

Dhakal, P., Lyden, E. R., Joshi, U., Pyakuryal, A., Gundabolu, K., & Bhatt, V. R. (2021). Association of Insurance Types and Survival in Acute Promyelocytic Leukemia (APL). Blood, 138 (Supplement 1), 4129. https://doi.org/10.1182/blood-2021-151055